Related Experiment Video
Updated: May 20, 2026
11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
Cognitive-behavioral therapy for pathological gambling in Parkinson's disease: a pilot controlled study
Susana Jiménez-Murcia1, Francesca Isabella Bove, Mimi Israel
1Department of Psychiatry, University Hospital of Bellvitge-IDIBELL, Barcelona, Spain. sjimenez@bellvitgehospital.cat
European Addiction Research
|July 5, 2012
Summary
Pathological gamblers with Parkinson's disease (PG + PD) were older with later gambling onset than those without (PG - PD). Despite clinical differences, both groups responded similarly to cognitive-behavioral treatment.
Area of Science:
- Neuroscience
- Psychiatry
- Behavioral Science
Background:
- Pathological gambling (PG) is a complex disorder.
- Comorbidity with Parkinson's disease (PD) presents unique clinical challenges.
- Understanding these differences is crucial for tailored interventions.
Purpose of the Study:
- To compare clinical characteristics of pathological gamblers with (PG + PD) and without (PG - PD) comorbid Parkinson's disease.
- To assess treatment response differences between these two groups.
Main Methods:
- A comparative study involving 15 PG + PD patients and 45 PG - PD patients.
- Assessment of clinical and psychopathological profiles.
- Evaluation of response to cognitive-behavioral treatment.
Main Results:
- PG + PD patients were older, had a later onset of gambling, lower alcohol consumption, and higher engagement in bingo compared to PG - PD patients.
- No significant differences in psychopathology were found, except for lower hostility in the PG + PD group.
- Treatment response to cognitive-behavioral therapy did not differ significantly between the groups.
Conclusions:
- Clinical profiles of pathological gamblers differ based on the presence of comorbid Parkinson's disease.
- Despite distinct characteristics, treatment efficacy for pathological gambling appears consistent across groups.
- Findings aid in identifying specific patient needs for targeted therapeutic strategies.
Related Concept Videos
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Operant Conditioning Intervention
Operant conditioning serves as a foundational principle in therapeutic interventions aimed at modifying maladaptive behaviors. Central to this approach is the notion that behaviors, both adaptive and maladaptive, are learned through reinforcement. By analyzing the environmental factors that reinforce problematic behaviors, clinicians can design interventions to weaken these reinforcements and replace maladaptive behaviors with healthier alternatives.
In operant conditioning, behaviors that are...
In operant conditioning, behaviors that are...